Class 3. Pulmonary Hypertension Associated with Lung Disease

Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia

B. A. Madden, M. R. Conaway, S. A. Zanelli, M. A. McCullochAnn and Robert H. Lurie Children’s Hospital of Chicago. University of Virginia and University of Virginia Children’s Hospital.United States Pediatric CardiologyPediatr Cardiol 2022; 43: 1743-1751DOI: 10.1007/s00246-022-02911-2 AbstractHypothesis: Premature infants with bronchopulmonary dysplasia (BPD) are at increased risk of secondary pulmonary hypertension (BPD-PH). Prior studies yielded mixed […]

Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia Read More »

Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network

Ga Young Park, Won Soon Park, MinSun Kim, Myung Hee Lee, Ga Won Jeon, Sung Shin Kim, Yun Sil ChangSoonchunhyang University Bucheon Hospital and Soonchunhyang University School of Medicine. Samsung Medical Center and Sungkyunkwan University School of Medicine. Inje University Busan Paik Hospital and Inje University College of Medicine.Republic of Korea Journal of Maternal Fetal

Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network Read More »

Neonatal intermittent hypoxia persistently impairs lung vascular development and induces long-term lung mitochondrial DNA damage

Andreas Damianos, Shathiyah Kulandavela, Pingping Chen, Patrick Nwajei, Sunil Batlahally, Mayank Sharma, Silvia Alvarez-Cubela, Juan Dominguez-Bendala, Ronald Zambrano, Jian Huang, Joshua M. Hare, Augusto Schmidt, Merline Benny, Nelson Claure, Karen YoungUniversity of Miami Miller School of Medicine.United States Journal of Applied PhysiologyJ Appl Physiol 2022; 133: 1031-1041DOI: 10.1152/japplphysiol.00708.2021 AbstractAdults born preterm have an increased risk of

Neonatal intermittent hypoxia persistently impairs lung vascular development and induces long-term lung mitochondrial DNA damage Read More »

The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia

Ryan J. Carpenter, Nina Srdanovic, Karen Rychlik, Shawn K. Sen, Nicholas F. M. Porta, Aaron E. Hamvas, Karna Murthy, Amanda L. HauckLurie Children’s Hospital of Chicago and Northwestern University.United States Journal of PerinatologyJ Perinatol 2022; 42: 788-795DOI: 10.1038/s41372-022-01386-6 AbstractObjective: To describe the association between echocardiographic measures of pulmonary vascular disease and time to respiratory improvement among infants

The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia Read More »

Deficiency in DDR1 Induces Pulmonary Hypertension and Impaired Alveolar Development

Quinn A. Bonafiglia, Yu-Qing Zhou, Guangpei Hou, Rhidita Saha, Ying-Han R. Hsu, Jonah Burke-Kleinman, Michelle P. BendeckUniversity of Toronto, Ted Rogers Centre for Heart Research and University Health Network.Canada American Journal of Respiratory Cell and Molecular BiologyAm J Respir Cell Mol Biol 2022; 67: 562-573DOI: 10.1165/rcmb.2022-0124OC AbstractPulmonary hypertension (PH) is a multifaceted condition characterized by elevated

Deficiency in DDR1 Induces Pulmonary Hypertension and Impaired Alveolar Development Read More »

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension

Hannes Sallmon, Martin Koestenberger, Alexander Avian, Friedrich Reiterer, Bernhard Schwaberger, Katharina Meinel, Gerhard Cvirn, Stefan Kurath-Koller, Andreas Gamillscheg, Georg HansmannEuropean Pediatric Pulmonary Vascular Disease Network. Charité-Universitätsmedizin Berlin. Deutsches Herzzentrum Berlin. Medical University Graz. Hannover Medical School. Germany and Austria Journal of PerinatologyJ Perinatol 2022; 42: 781-787DOI: 10.1038/s41372-022-01374-w AbstractObjective: Extremely low gestational age newborns (ELGANs) represent an especially

Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension Read More »

Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension

Mayank Sharma, Michael A. Bellio, Merline Benny, Shathiyah Kulandavelu, Pingping Chen, Chawisa Janjindamai, Chenxu Han, Liming Chang, Shanique Sterling, Kevin Williams, Andreas Damianos, Sunil Batlahally, Kaitlyn Kelly, Daniela Aguilar-Caballero, Ronald Zambrano, Shaoyi Chen, Jian Huang, Shu Wu, Joshua M. Hare, Augusto Schmidt, Aisha Khan, Karen YoungUniversity of Miami Miller School of Medicine.United States Stem Cells Translational Medicine Stem Cells Transl Med 2022; 11: 828-840DOI: 10.1093/stcltm/szac041 AbstractMesenchymal stem cell (MSC) extracellular vesicles (EVs) have beneficial effects in preclinical bronchopulmonary

Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension Read More »

Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension

Catherine M. Avitabile, Xuemei Zhang, Steve B. Ampah, Yan Wang, Devon Ash, Kathleen Nilan, Laura Mercer-Rosa, Julie L. Fierro, David B. Frank, Kathleen A. GibbsUniversity of Pennsylvania and Children’s Hospital of Philadelphia.United States Journal of PerinatologyJ Perinatol 2022; 42: 1246-1254DOI: 10.1038/s41372-022-01421-6 AbstractObjective: To evaluate factors associated with discontinuation of pulmonary vasodilator therapy in bronchopulmonary dysplasia-related pulmonary hypertension

Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension Read More »

Late onset of pulmonary hypertension in very low birth weight infants

Joseph Ginski, Dmitry Tumin, Devon Kuehn, Jason Higginson, Scott MacGilvrayEast Carolina UniversityUnited States Journal of Maternal Fetal and Neonatal MedicineJ Matern Fetal Neonatal Med 2022; 35: 3516-3518DOI: 10.1080/14767058.2020.1826924 AbstractIntroduction: Pulmonary hypertension (PH) is a recognized complication of bronchopulmonary dysplasia (BPD). Recent guidelines recommend evaluating all infants with BPD for PH via echocardiogram, but the specific timing of this screening

Late onset of pulmonary hypertension in very low birth weight infants Read More »

The Clinical and Cost Utility of Cardiac Catheterizations in Infants with Bronchopulmonary Dysplasia

Emily L. Yang, Philip T. Levy, Paul J. Critser, Dmitry Dukhovny, Patrick D. EversOregon Health and Sciences University. Harvard Medical School and Boston Children’s Hospital. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center.United States Journal of PediatricsJ Pediatr 2022; 246: 56-63DOI: 10.1016/j.jpeds.2022.04.009

The Clinical and Cost Utility of Cardiac Catheterizations in Infants with Bronchopulmonary Dysplasia Read More »

Scroll to Top